We are live on ! Find out more
IFRX icon

InflaRx

25 hedge funds and large institutions have $7.08M invested in InflaRx in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more call options, than puts

Call options by funds: $30K | Put options by funds: $2K

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.37% less ownership

Funds ownership: 8.46% → 8.09% (-0.37%)

24% less funds holding

Funds holding: 33 → 25 (-8)

55% less capital inflows, than outflows

Capital inflows: $431K | Capital outflows: $951K

89% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 9

Holders
25
Holders Change
-8
Holders Change %
-24.24%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
5
Closed
9
Calls
$30K
Puts
$2K
Net Calls
+$28K
Net Calls Change
+$13K

IFRX Hedge Fund Activity: Q1 2023 in Review

25 of the 6,289 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q1 2023, worth a combined $7.08M — down 39% from $11.6M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of IFRX and 1 opened new positions — a net loss of 8 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Susquehanna International Group, adding an estimated $170K. The largest seller was Millennium Management, exiting entirely with an estimated $377K sold.

  • 25 institutional investors held InflaRx (IFRX) as of Q1 2023, down from 33 in Q4 2022.
  • Funds reported $7.08M of InflaRx stock for Q1 2023, down 39% quarter-over-quarter.
  • 1 fund opened new InflaRx positions in Q1 2023 and 9 closed out, a net change of -8 holders.
  • The largest InflaRx buyer in Q1 2023 was Susquehanna International Group, an estimated $170K added.
  • The largest InflaRx seller in Q1 2023 was Millennium Management, an estimated $377K sold.

Based on aggregated 13F filings for Q1 2023.